Medicines and Healthcare Products Regulatory Agency

Department for Exiting the European Union written question – answered at on 21 July 2017.

Alert me about debates like this

Photo of Tom Brake Tom Brake Liberal Democrat Spokesperson (International Trade), Liberal Democrat Spokesperson (Exiting the European Union)

To ask the Secretary of State for Exiting the European Union, what recent assessment the Government has made of the effect on the (a) funding and (b) staffing of the Medicines and Healthcare Products Regulatory Agency of the UK leaving the EU.

Photo of Robin Walker Robin Walker The Parliamentary Under-Secretary of State for Exiting the European Union

The Department for Exiting the EU is working closely with every department to build a detailed understanding of how withdrawal will affect domestic policies and to ensure that departments are prepared for all possible negotiating outcomes. All departments are equipping themselves with the resources they need to get the best deal for the UK. As an arm's length body of the Department of Health and the National Competent Authority for the UK in the field of human and veterinary medicine, MHRA funding and staffing concerns are being considered as part of the domestic planning for withdrawal.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.